Home > Quotes > NOVN

Novan, Inc. Common Stock (NOVN) Quote & Summary Data

Get NOVN Alerts
*Delayed - data as of Dec. 14, 2018  -  Find a broker to begin trading NOVN now
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 1.4599 / $ 1.25
Share Volume
50 Day Avg. Daily Volume
Previous Close
$ 1.40
52 Week High / Low
$ 4.77 / $ 1.23
Market Cap
Annualized Dividend
Ex Dividend Date
Dividend Payment Date
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
50 Day Avg. Daily Volume:

P/E Ratio

P/E Ratio:
Forward P/E (1y):
Earnings Per Share (EPS):
$ -1.28

Trading Range

The current last sale of $1.2791 is 3.99% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.4599 $ 4.77
 Low: $ 1.25 $ 1.23

ETFs with NOVN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
13.48% iShares Inc iShares MSCI Switzerland ETF (EWL) -1.41 (-4.15%)
4.46% iShares Global Healthcare ETF (IXJ) +1.66 (2.82%)
4.36% iShares Edge MSCI Intl Momentum Factor ETF (IMTM) -3.21 (-10.69%)
3.4% iShares Trust (IGRO) -5.41 (-9.64%)
2.84% iShares Europe ETF (IEV) -5.08 (-11.15%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a clinical-stage biotechnology company focused on leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Nitric oxide plays a vital role in the natural immune system response against microbial pathogens and is a critical regulator of inflammation. Our ability to harness nitric oxide and its multiple mechanisms of action has enabled us to create a platform with the potential to generate differentiated product candidates. The two key components of our nitric oxide platform are our proprietary Nitricil technology, which drives the creation of new chemical entities, or NCEs, and our topical formulation science, both of which we use to tune our product candidates for specific indications. We believe that the ability to deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to improve patient outcomes in a variety of diseases.  ... More ...  

Risk Grade

Where does NOVN fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.38
Open Date:
Dec. 14, 2018
Close Price:
$ 1.27
Close Date:
Dec. 14, 2018

Consensus Recommendation

Analyst Info